Covalent inhibitors design and discovery.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Covalent drugs represent a distinct and significant class of therapeutics.
• Despite their prevalence, few covalent drugs are intentionally designed for specific targets.
• Understanding covalent interactions is crucial for developing targeted therapies.

Purpose of the Study:

• To review the prevalence and mechanisms of covalent drugs.
• To outline strategies for the discovery and development of safe and effective covalent enzyme inhibitors.
• To discuss computational methods in covalent drug design.

Main Methods:

• Literature review of covalent drug prevalence and mechanisms.
• Discussion of drug discovery stages for covalent inhibitors, including target selection and lead optimization.
• Analysis of strategies for tuning reactivity and computational approaches.

Main Results:

• Covalent drugs have a notable presence in the market, with diverse mechanisms of action.
• Systematic approaches are required for the rational design of covalent enzyme inhibitors.
• Computational tools offer potential but have limitations in predicting covalent interactions.

Conclusions:

• Covalent drugs require careful design and assessment due to their unique reactivity.
• Best practices are needed for developing safe and efficient covalent inhibitors.
• Further advancements in computational methods are essential for optimizing covalent drug discovery.